Showing 1 - 3 results of 3 for search 'Hidetaka Matsumoto', query time: 0.01s Refine Results
  1. 1
    Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration.

    Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration. by Ryo Mukai, Hidetaka Matsumoto, Hideo Akiyama

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Thinking Beyond Wet Age-Related Macular Degeneration

    Thinking Beyond Wet Age-Related Macular Degeneration by Neha Goel, Atul Kumar, Mahesh P Shanmugam, Muna Bhende, Raja Narayanan, Hidetaka Matsumoto

    Published 2016-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study

    Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study by Masayuki Ohnaka, Yoichi Sakurada, Atsushi Hayashi, Kazuaki Kadonosono, Hitoshi Ohno, Ryusaburo Mori, Hidetaka Matsumoto, Ippei Nagamori, Yuki Murata, Tina Maio-Twofoot, Helene Karcher, Hidenori Takahashi

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: